Shop Apotheke Europe NV
OTC:SHPPF
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| NL |
S
|
Shop Apotheke Europe NV
XETRA:SAE
|
1.8B EUR |
Loading...
|
|
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
76.4B ZAR |
Loading...
|
|
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
31.2B ZAR |
Loading...
|
|
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD |
Loading...
|
|
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
44.6B BRL |
Loading...
|
|
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
1.2T JPY |
Loading...
|
|
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
1.1T JPY |
Loading...
|
|
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR |
Loading...
|
|
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
30.5B CNY |
Loading...
|
|
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
677.7B JPY |
Loading...
|
|
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY |
Loading...
|
Market Distribution
| Min | -3 388.8% |
| 30th Percentile | 29.2% |
| Median | 45.1% |
| 70th Percentile | 64.1% |
| Max | 4 855.5% |
Other Profitability Ratios
Shop Apotheke Europe NV
Glance View
Shop Apotheke Europe NV has carved a unique niche for itself within the healthcare market, establishing itself as one of Europe's leading online pharmacies. Founded in 2001, the company’s journey began in Germany, where it initially catered to a growing demand for convenience in health and pharmaceutical shopping. Capitalizing on the increasing trend towards digitalization, Shop Apotheke expanded its operations beyond German borders, servicing a wide European market that spans countries such as Austria, France, Belgium, and the Netherlands. The company's core business model revolves around the efficient delivery of prescription and over-the-counter medications, along with a diverse assortment of beauty and wellness products. By leveraging a robust logistical framework and adopting an expansive product catalog strategy, the company ensures that customers can gain access to a comprehensive range of health solutions from the comfort of their homes. The economic engine of Shop Apotheke Europe lies in its adept utilization of e-commerce capabilities, driving revenue primarily through the sales of pharmaceutical goods and wellness products. By operating within a dynamic online platform, it leverages economies of scale, allowing for competitive pricing and streamlined operations that ultimately enhance customer satisfaction. Additionally, the company benefits from its strategic partnerships with an array of pharmaceutical manufacturers, ensuring a steady supply of products at optimal costs. As a digital-first enterprise, Shop Apotheke also invests heavily in marketing, data analytics, and technological infrastructure to strengthen customer acquisition and retention. Its business strategy is further bolstered by a customer-centric approach, focusing on transparency and the seamless integration of healthcare solutions into everyday life, hence solidifying its standing as a trusted partner in the journey towards better health across Europe.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
Over the last 2 years, Shop Apotheke Europe NV’s Gross Margin has increased from 22.7% to 27.5%. During this period, it reached a low of 22.7% on Dec 1, 2020 and a high of 27.5% on Jan 31, 2023.